Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Updated recommendations, panel sessions among highlights at 21st annual WCIRDC meeting
Presentations on the latest cardiometabolic research, panel discussions and updated practice recommendations are among this year’s highlights at the 21st World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.
Mycobacterial infections rare among people with diabetic foot infections
Clinicians and microbiologists who care for patients with diabetic foot infections may be able to decrease the use of mycobacterial cultures and health care costs because these infections are uncommon, according to study data.
Log in or Sign up for Free to view tailored content for your specialty!
Cost of diabetes care in US rises to $412.9 billion in 2022
The total annual cost of caring for Americans with diabetes in 2022 was an estimated $412.9 billion, and one in four total health care dollars in the U.S. went toward diabetes care, according to a report.
Severe anion gap metabolic acidosis in a patient with type 2 diabetes
A man aged 51 years with a history of alcohol use disorder and type 2 diabetes treated with metformin and glimepiride and alcohol presented to the hospital for a witnessed cardiac arrest at home.
DNA methylation markers may help predict diabetic kidney disease progression
Using DNA methylation markers in blood samples may help predict the progression of diabetic kidney disease in patients with type 2 diabetes, recent data suggests.
Meta-analysis confirms benefits of SGLT2 inhibitors in various high-risk populations
SGLT2 inhibitors reduce risk for CV death and HF events in patients with any or multiple of HF, type 2 diabetes and chronic kidney disease, according to a meta-analysis published in the Journal of the American College of Cardiology.
VIDEO: ‘We have amazing tools today’ to reduce cardiometabolic complications
PHILADELPHIA — In this Healio video exclusive, Mikhail Kosiborod, MD, FACC, FAHA, co-chair of the Heart in Diabetes CME Conference, discusses the accomplishments of the meeting.
Finerenone may improve kidney disease-related CV complications in type 2 diabetes
Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, may improve CV risk among patients with type 2 diabetes and kidney disease and those with albuminuria, according to a FIDELITY substudy published in JAMA Cardiology.
VIDEO: In COVID-19, MI risk elevated with at least one cardiometabolic risk factor
PHILADELPHIA — In this Healio video exclusive, Healio | Cardiology Today Editorial Board Member Susan Cheng, MD, MPH, MMSc, discusses the excess risk for heart attack in patients with COVID-19.
PAD plus diabetes ‘unique’ malignant phenotype; proper medical therapy essential
PHILADELPHIA — Peripheral artery disease is often the first manifestation of CVD in patients with type 2 diabetes, and represents a “unique” malignant phenotype, a speaker said during the Heart in Diabetes CME Conference.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read